Assessment of awareness of pre-exposure prophylaxis methods against HIV infection among healthcare specialists, medical students, and charitable foundation volunteers


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To assess awareness of pre-exposure prophylaxis (PrEP) against HIV infection among healthcare specialists, medical students, and charitable foundation volunteers. Subjects and methods. The investigation involved respondents of 3 groups. Group 1 consisted of 73 healthcare workers; Group 2 included 75 five- and six-year medical students of faculties of pediatrics, general medicine, and medicine; Group 3 comprised of 26 volunteers of the «Shagi» (Steps) Regional Charitable Public AIDS Control Foundation. All the groups underwent a survey using the continuous sampling on the days of both face-to-face and Internet surveys. Results. The mean HIV PrEP awareness self-assessment score was 5.36 in Group 1, 4.88 in Group 2, and 5.69 in Group 3. Group 1 respondents mainly received information about the method from scientific literature, in the learning process, and from the Internet (25.9, 22.2, and 12.9, respectively). Group 2 respondents did this in the process of learning, from the Internet, from scientific literature (42.4, 32.2, and 15.3%, respectively). The charitable foundation employees did this in the process of learning, from the Internet, from scientific literature (46,2, 36,6, and 15,4%, respectively). Respondents in this group mentioned PrEP more often when answering an indicator question about the HIV transmission prevention methods known to them (p < 0.05). Conclusion. Poor self-awareness among the surveyed medical professionals, medical students, and non-profit organization employees is one of the main barriers to PrEP method use.

全文:

受限制的访问

作者简介

Ulyana Kuimova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: ulyanakuimova@gmail.com
Cand. Med. Sci., Researcher, Central Research Institute of Epidemiology

Valentina Belyaeva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: labora-et-ora@yandex.ru
МD, Leading Researcher

Nadezhda Kozyrina

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: nad-kozyrina@yandex.ru
Cand. Med. Sci., Senior Researcher

Ekaterina Kulabukhova

Peoples' Friendship University of Russia

Email: ekulabukhova@mail.ru
Cand. Med. Sci., Infectiologist

Marina Goliusova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: mad2501@yandex.ru
Infectiologist, Central Research Institute of Epidemiology

Irina Kuimova

Novosibirsk State Medical University

Email: kuimova_ira@mail.ru
МD, Professor, Department of Infectious Diseases

参考

  1. Holmes D. FDA paves the way for pre-exposure HIV prophylaxis. Lancet 2012; 380: 325.
  2. Hodges-Mameletzis I., Dalal S., Msimanga-Radebe B., Rodolph M., Baggaley R. Going global: the adoption of the World Health Organization’s enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health 2018; 15(6): 489-500. doi: 10.1071/SH18125
  3. Anderson P., Glidden D.V., Liu A., Buchbinder S., Lama J.R., Cuaniro J. et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci. Transl. Med. 2012; 4(151): 151ra125. doi: 10.1126/scitranslmed.3004006
  4. Molina J.M., Capitant С., Spire B., Pialoux G., Chidiac C., Charreau I. et al. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial. CROI 2015. 2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015), 23-26 February 2015. Seattle, Washington, USA. Oral late breaker abstract 23LB. http://www.croiconference.org/sessions/demand-prep-oral-tdf-ftc-msm-results-anrs-ipergay-trial
  5. PrEP for HIV Prevention in the U.S. https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/PrEP-for-hiv-prevention-in-the-US-factsheet.html
  6. FDA NEWS RELEASE. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention
  7. Ефремова О.С., Беляева В.В., Козырина Н.В., Куимова У.А., Покровская А.В., Суворова З.К. Оценка информированности ВИЧ-инфицированных пациентов о методике доконтактной профилактики, отношения к ее проведению и перспектив проведения в России. Эпидемиол. инфекц. болезни. Актуал. вопр. 2020; 10(3): 99-104. https://dx.doi.org/10.18565/epidem.2020.10.3.99-104
  8. Беляева В.В., Козырина Н.В., Куимова У.А., Голиусова М.Д., Ефремова О.С. Профилактика передачи ВИЧвдискордантных парах: информированность, осознание риска, поведение. Инфекционные болезни: новости, мнения, обучение 2021; 10(1): 46-51. https://doi.org/10.33029/2305-3496-2021-10-1-46-51

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2022
##common.cookie##